《歐股業績》瑞銀首季純利升17.1%勝預期 進一步減少俄羅斯業務敞口
瑞銀(UBS)公佈首季業績,集團經營收入93.63億美元,按年升7.6%。由於俄烏衝突刺激交易活動增加,首季純利21.36億美元,按年升17.1%,勝市場預期的17.9億美元。每股攤薄盈利0.61美元。
該行稱,在俄羅斯入侵烏克蘭、新冠相關封城措施、更高波動性、經濟展望下滑,以及市場憂慮高通脹下貨幣政策迴應等,宏觀經濟、地緣政治及市場因素在首季帶來重大不確定性。
瑞銀指正在進一步減少俄羅斯業務敞口。該行早前發表去年年報,形容對俄羅斯市場風險敞口有限,去年直接業務敞口僅6.34億美元,該行新興市場敞口總值達209億美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.